Recently we have seen significant strides made in understanding the causes of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. On the therapeutic side, a small number of promising treatments are now moving forward in clinical trials.
Yet despite these causes for optimism, the scientific and medical research community continues to be grossly underfunded. Additionally, the urgent needs of the ALS patient community, including families and caregivers, constantly exceed available resources.
For far too long, the world at large has been acutely deficient in its knowledge of ALS. And the sad fact remains that there is still no cure for ALS, and meaningful, efficacious treatments to slow its progression are still unavailable.
Therefore, the mission of the Robert A. Stehlin Campaign for Amyotrophic Lateral Sclerosis (RASCALS) Foundation is threefold:
Raise awareness of ALS by serving as an educational resource
RASCALS is developing and providing to communities:
- General disease state information from accredited medical sources
- Reports on trends in ALS research and treatment from scientific journals
- Directory of ALS-centric organizations and educational resources
This important information is made available through Internet channels, published materials, and mass media.
Grant funding to the medical and therapeutic research community
RASCALS allocates a portion of the proceeds from its fundraising activities to university schools of medicine and other research concerns specializing in ALS.
Award invaluable financial assistance to the ALS patient community
RASCALS is helping to offset the economic burdens of ALS through a higher education scholarship program that’s available to families affected by the disease.